Approach to the profiling and characterization of influenza vaccine constituents by the combined use of size-exclusion chromatography, gel electrophoresis and mass spectrometry

Ferguson, 2003, Ecological and immunological determinants of influenza evolution, Nature, 422, 428, 10.1038/nature01509 Health Canada Dobbelaer R, Levandowsky R, Wood J. Annex 3. Recommendations for the production and control of influenza vaccine (inactivated). WHO technical report series, No. 927; 2005. Heiny, 2007, Evolutionarily Conserved protein Sequences of influenza A viruses, Avian and Human, as vaccine Targets, PLoS ONE, 2, e1190, 10.1371/journal.pone.0001190 Calam, 1984, Isolation of influenza viral proteins by size-exclusion and ion-exchange high performance liquid chromatography: the influence of conditions on separation, J Chromatogr, 296, 285, 10.1016/S0021-9673(01)96422-2 Tanimoto, 2005, Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography, Vaccine, 23, 4598, 10.1016/j.vaccine.2005.04.042 Phelan, 1983, Gradient optimization principles in reversed-phase high performance liquid chromatography and the separation of Influenza virus components, J Chromatogr, 266, 55, 10.1016/S0021-9673(01)90879-9 Kaptein, 2006, Hemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method, Vaccine, 14, 3137, 10.1016/j.vaccine.2006.01.046 Garcia-Cañas, 2006, Rapid and selective characterization of influenza virus constituents in monovalent and multivalent preparations using non-porous reversed-phase high performance liquid chromatography columns, J Chromatogr A, 1123, 225, 10.1016/j.chroma.2006.04.003 Garcia-Cañas, 2007, Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection, Anal Chem, 79, 3164, 10.1021/ac0621120 Williams, 2008, Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry, Vaccine, 26, 2510, 10.1016/j.vaccine.2008.03.014 Welling, 2002, 513 Welling, 1989 Cromwell, 2006, Protein aggregation and bioprocessing, AAPS J, 8, E572, 10.1208/aapsj080366 Lamb, 1985, Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface, Cell, 40, 627, 10.1016/0092-8674(85)90211-9 Enami, 1996, Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein, J Virol, 70, 6653, 10.1128/JVI.70.10.6653-6657.1996 Ye, 1999, Association of influenza virus matrix protein with ribonucleoproteins, J Virol, 73, 7467, 10.1128/JVI.73.9.7467-7473.1999 Ye, 2006, The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA, Nature, 444, 1078, 10.1038/nature05379 Prokudina, 2008, An antigenic epitope of influenza virus nucleoprotein (NP) associated with polymeric forms of NP, Virol J, 5, 37, 10.1186/1743-422X-5-37 Laver, 1969, Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus, Virology, 38, 105, 10.1016/0042-6822(69)90132-9 Webster, 1969, Disruption of myxoviruses with Tween 20 and isolation of biologically active hemagglutinin and neuraminidase subunits, J Virol, 4, 182, 10.1128/JVI.4.2.182-187.1969 Webster, 1970, Estimation of the molecular weights of the polypeptide chains from the isolated hemagglutinin and neuraminidase subunits of influenza viruses, Virology, 40, 643, 10.1016/0042-6822(70)90209-6 Pons, 1969, Isolation and characterization of the ribonucleoprotein of influenza virus, Virology, 39, 250, 10.1016/0042-6822(69)90045-2